Published in Lancet on January 29, 1994
From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr Rev (2010) 3.11
Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J Biol Chem (2007) 2.73
A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest (2003) 2.37
Estrogen receptor alpha is a major mediator of 17beta-estradiol's atheroprotective effects on lesion size in Apoe-/- mice. J Clin Invest (2001) 1.45
Mitochondrial mechanisms of estrogen neuroprotection. Biochim Biophys Acta (2009) 1.25
Alterations in EDHF-mediated hyperpolarization and relaxation in mesenteric arteries of female rats in long-term deficiency of oestrogen and during oestrus cycle. Br J Pharmacol (2001) 1.20
Estrogen actions on mitochondria--physiological and pathological implications. Mol Cell Endocrinol (2008) 1.11
Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production. Proc Natl Acad Sci U S A (1996) 1.04
Oestrogen metabolites in relation to isoprostanes as a measure of oxidative stress. Clin Endocrinol (Oxf) (2007) 0.99
Accelerated cell aging in female APOE-ε4 carriers: implications for hormone therapy use. PLoS One (2013) 0.98
Can estrogen keep you smart? Evidence from clinical studies. J Psychiatry Neurosci (1999) 0.91
Sex-based differences in cardiac ischaemic injury and protection: therapeutic implications. Br J Pharmacol (2014) 0.91
Inhibition of NADPH oxidases prevents chronic ethanol-induced bone loss in female rats. J Pharmacol Exp Ther (2010) 0.89
The potential for estrogens in preventing Alzheimer's disease and vascular dementia. Ther Adv Neurol Disord (2009) 0.87
Human cytomegalovirus increases modified low density lipoprotein uptake and scavenger receptor mRNA expression in vascular smooth muscle cells. J Clin Invest (1996) 0.87
17beta-estradiol prevents early-stage atherosclerosis in estrogen receptor-alpha deficient female mice. J Cardiovasc Transl Res (2009) 0.85
Polymorphism of rs873308 near the transmembrane protein 57 gene is associated with serum lipid levels. Biosci Rep (2014) 0.85
Significant reduction of the antiatherogenic effect of estrogen by long-term inhibition of nitric oxide synthesis in cholesterol-clamped rabbits. J Clin Invest (1997) 0.84
Patients with sickle cell anemia on simple chronic transfusion protocol show sex differences for hemodynamic and hematologic responses to transfusion. Transfusion (2012) 0.83
Differential effects of glucose on agonist-induced relaxations in human mesenteric and subcutaneous arteries. Br J Pharmacol (2007) 0.82
Sex differences in inflammation during atherosclerosis. Clin Med Insights Cardiol (2015) 0.80
Estrogen-induced SDF-1 production is mediated by estrogen receptor-α in female hearts after acute ischemia and reperfusion. Surgery (2011) 0.80
Aggregation and fusion of low-density lipoproteins in vivo and in vitro. Biomol Concepts (2013) 0.80
Energy expenditure and plasma F2-isoprostanes across the menstrual cycle. Med Sci Sports Exerc (2011) 0.78
Cardiovascular Diseases, Aging and the Gender Gap in the Human Longevity. J Am Soc Hypertens (2007) 0.78
Reduction of post injury neointima formation due to 17beta-estradiol and phytoestrogen treatment is not influenced by the pure synthetic estrogen receptor antagonist ICI 182,780 in vitro. BMC Cardiovasc Disord (2002) 0.77
Role of endogenous testosterone in TNF-induced myocardial injury in males. Int J Clin Exp Med (2012) 0.76
G-protein-coupled estrogen receptor as a new therapeutic target for treating coronary artery disease. World J Cardiol (2014) 0.76
Effect of estrogen replacement therapy on lens epithelial cell apoptosis in an experimental rat model. Int Ophthalmol (2009) 0.76
Analysis of oxidative stress during the menstrual cycle. Reprod Biol Endocrinol (2013) 0.76
Anti-atherogenic action of oestrogen. Lancet (1994) 0.75
Pregnancy followed by delivery may affect circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in women of reproductive age. Mediators Inflamm (2012) 0.75
Anti-atherogenic action of oestrogen. Lancet (1994) 0.75
Fibrinolytic potential is significantly increased by oestrogen treatment in postmenopausal women with mild dyslipidaemia. Heart (1998) 0.75
Low estrogen levels and obesity are associated with shorter telomere lengths in pre- and postmenopausal women. J Exerc Rehabil (2016) 0.75
Anti-atherogenic action of oestrogen. Lancet (1994) 0.75
Combined oestrogen-progestogen replacement therapy does not inhibit low-density lipoprotein oxidation in postmenopausal women. Br J Clin Pharmacol (1999) 0.75
Endothelial Dysfunction Markers in Low Cardiovascular Risk Individuals: Comparison of Males and Females. J Med Biochem (2017) 0.75
Human immunodeficiency virus infection among patients attending clinics for sexually transmitted diseases. N Engl J Med (1988) 4.81
Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons. Mayo Clin Proc (1999) 3.32
Sympathetic cardioneuropathy in dysautonomias. N Engl J Med (1997) 3.14
Cardiac sympathetic denervation in Parkinson disease. Ann Intern Med (2000) 2.97
Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1). N Engl J Med (1987) 2.88
Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice. Circulation (1999) 2.84
A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia. Nat Med (1995) 2.65
Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients. Circulation (1989) 2.56
A novel endothelial-derived lipase that modulates HDL metabolism. Nat Genet (1999) 2.56
Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice. J Clin Invest (1999) 2.54
A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med (1989) 2.45
Role of circulating nitrite and S-nitrosohemoglobin in the regulation of regional blood flow in humans. Proc Natl Acad Sci U S A (2000) 2.41
Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals. J Infect Dis (1992) 2.25
Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science (1992) 2.24
Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (2). N Engl J Med (1987) 2.18
Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemia. Nature (1993) 2.05
The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation. J Clin Invest (2001) 2.04
Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse. Arterioscler Thromb Vasc Biol (2000) 2.02
Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice. Nat Med (1998) 1.98
Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. Circulation (1995) 1.84
Angina caused by reduced vasodilator reserve of the small coronary arteries. J Am Coll Cardiol (1983) 1.82
Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. Circulation (1985) 1.81
Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases. J Infect Dis (1994) 1.78
Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis. J Clin Invest (1995) 1.69
The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice. J Clin Invest (1997) 1.67
Selective loss of microvascular endothelial function in human hypercholesterolemia. Circulation (1994) 1.66
Oral L-arginine in patients with coronary artery disease on medical management. Circulation (2000) 1.65
Vasodilator response to systemic but not to local hyperinsulinemia in the human forearm. Hypertension (1998) 1.61
Role of nitric oxide in the vasodilator response to mental stress in normal subjects. Am J Cardiol (1997) 1.61
MDR and PRP: a comparison of methods for high-order genotype-phenotype associations. Hum Hered (2004) 1.59
Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases. N Engl J Med (1992) 1.56
The association of syphilis with risk of human immunodeficiency virus infection in patients attending sexually transmitted disease clinics. Arch Intern Med (1990) 1.55
Prospective identification by two-dimensional echocardiography of anomalous origin of the left main coronary artery from the right sinus of Valsalva. Am J Cardiol (1991) 1.48
Association of biologic false-positive reactions for syphilis with human immunodeficiency virus infection. J Infect Dis (1992) 1.46
Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein e-deficient mice. Circulation (2001) 1.46
Overexpression of secretory phospholipase A(2) causes rapid catabolism and altered tissue uptake of high density lipoprotein cholesteryl ester and apolipoprotein A-I. J Biol Chem (2000) 1.45
Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation (1994) 1.45
Deficiency in inducible nitric oxide synthase results in reduced atherosclerosis in apolipoprotein E-deficient mice. J Immunol (2000) 1.43
The effect of coronary artery bypass grafting on left ventricular systolic function at rest: evidence for preoperative subclinical myocardial ischemia. Am J Cardiol (1988) 1.42
Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein B. J Lipid Res (1999) 1.40
Characterization of antibody reactivity to human T-cell lymphotropic virus types I and II using immunoblot and radioimmunoprecipitation assays. J Clin Microbiol (1990) 1.40
Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy. Circulation (1992) 1.39
Acute vascular effects of estrogen in postmenopausal women. Circulation (1994) 1.39
Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients. Hypertension (1997) 1.38
Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. Circulation (1995) 1.38
Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples. Blood (1991) 1.37
Role of endothelin in the increased vascular tone of patients with essential hypertension. Hypertension (1999) 1.34
Severe mitral or aortic valve regurgitation, or both, requiring valve replacement for infective endocarditis complicating hypertrophic cardiomyopathy. J Am Coll Cardiol (1992) 1.32
Mixed modelling to characterize genotype-phenotype associations. Stat Med (2005) 1.31
Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med (1988) 1.31
Racial differences in nitric oxide-mediated vasodilator response to mental stress in the forearm circulation. Hypertension (1998) 1.26
Vascular effects of estrogen and vitamin E therapies in postmenopausal women. Circulation (1999) 1.24
Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E. J Biol Chem (2001) 1.23
Sympathetically mediated effects of mental stress on the cardiac microcirculation of patients with coronary artery disease. Am J Cardiol (1995) 1.22
Cardiovascular complications in renal failure. J Am Soc Nephrol (1991) 1.21
Left ventricular dysfunction in patients with angina pectoris, normal epicardial coronary arteries, and abnormal vasodilator reserve. Circulation (1985) 1.21
Attenuation of cyclic nucleotide-mediated smooth muscle relaxation in blacks as a cause of racial differences in vasodilator function. Circulation (1999) 1.19
Clinical evaluation of impedance cardiography. Clin Physiol (1986) 1.18
Decreased vasodilator response to isoproterenol during nitric oxide inhibition in humans. Hypertension (1997) 1.18
Endothelial dysfunction in patients with chest pain and normal coronary arteries. Circulation (1992) 1.17
Group counseling to prevent sexually transmitted disease and HIV: a randomized controlled trial. Sex Transm Dis (1998) 1.17
Rapid regression of atherosclerosis induced by liver-directed gene transfer of ApoE in ApoE-deficient mice. Arterioscler Thromb Vasc Biol (1999) 1.16
Systemic amyloidosis presenting with angina pectoris. Ann Intern Med (1999) 1.16
The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women. Circulation (1997) 1.14
Effects of the antiestrogen tamoxifen on low-density lipoprotein concentrations and oxidation in postmenopausal women. Am J Cardiol (1995) 1.14
Interactions between nitric oxide and endothelin in the regulation of vascular tone of human resistance vessels in vivo. Hypertension (2000) 1.12
Infection with human T lymphotropic virus types I and II in sexually transmitted disease clinics in Baltimore and New Orleans. J Infect Dis (1992) 1.12
Inflammatory markers of coronary risk. N Engl J Med (2000) 1.10
Competition for p300 regulates transcription by estrogen receptors and nuclear factor-kappaB in human coronary smooth muscle cells. Circ Res (2000) 1.10
Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women. N Engl J Med (1997) 1.07
Impaired forearm vasodilator reserve in patients with microvascular angina. Evidence of a generalized disorder of vascular function? N Engl J Med (1987) 1.07
Safety and feasibility of liver-directed ex vivo gene therapy for homozygous familial hypercholesterolemia. Ann Surg (1996) 1.06
Prolonged correction of hyperlipidemia in mice with familial hypercholesterolemia using an adeno-associated viral vector expressing very-low-density lipoprotein receptor. Mol Ther (2000) 1.05
Hepatic apolipoprotein E expression promotes very low density lipoprotein-apolipoprotein B production in vivo in mice. J Lipid Res (2000) 1.05
Noninvasive determination of spatially resolved and time-resolved tissue perfusion in humans during nitric oxide inhibition and inhalation by use of a visible-reflectance hyperspectral imaging technique. Circulation (2001) 1.03
Cardiovascular effects of estrogen and lipid-lowering therapies in postmenopausal women. Circulation (1996) 1.03
Cardiovascular risk assessment based on US cohort studies: findings from a National Heart, Lung, and Blood institute workshop. Circulation (2001) 1.03
Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency. J Clin Invest (1993) 1.03
ABC1: connecting yellow tonsils, neuropathy, and very low HDL. J Clin Invest (1999) 1.03
Investigation of the mechanism of chest pain in patients with angiographically normal coronary arteries using transesophageal dobutamine stress echocardiography. J Am Coll Cardiol (1997) 1.02
Morphologic basis for obstruction to right ventricular outflow in hypertrophic cardiomyopathy. Am J Cardiol (1993) 1.00
A 30-amino acid truncation of the microsomal triglyceride transfer protein large subunit disrupts its interaction with protein disulfide-isomerase and causes abetalipoproteinemia. J Biol Chem (1995) 1.00
Efficacy of calcium channel blocker therapy for angina pectoris resulting from small-vessel coronary artery disease and abnormal vasodilator reserve. Am J Cardiol (1985) 0.98
Effect of L-arginine on human coronary endothelium-dependent and physiologic vasodilation. J Am Coll Cardiol (1997) 0.98
Chest pain as a consequence of abnormal visceral nociception. Dig Dis Sci (1993) 0.98
The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life. J Clin Endocrinol Metab (1999) 0.98
Differences in coronary flow and myocardial metabolism at rest and during pacing between patients with obstructive and patients with nonobstructive hypertrophic cardiomyopathy. J Am Coll Cardiol (1987) 0.97
Antioxidant effect of estrogen on cytomegalovirus-induced gene expression in coronary artery smooth muscle cells. Circulation (2000) 0.97
Hemodynamic principles in the control of coronary blood flow. Am J Cardiol (1985) 0.97
Evaluation of apoA-I kinetics in humans using simultaneous endogenous stable isotope and exogenous radiotracer methods. J Lipid Res (1993) 0.96
Initial results of combined anterior mitral leaflet plication and ventricular septal myotomy-myectomy for relief of left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy. Circulation (1992) 0.96
Increased activity of endogenous endothelin in patients with hypercholesterolemia. J Am Coll Cardiol (2000) 0.96
Pharmacological management of high triglycerides and low high-density lipoprotein cholesterol. Curr Opin Pharmacol (2001) 0.96
Expression of serum amyloid A protein in the absence of the acute phase response does not reduce HDL cholesterol or apoA-I levels in human apoA-I transgenic mice. J Lipid Res (1999) 0.95
Apolipoprotein(a) deposition in atherosclerotic plaques of cerebral vessels. A potential role for endothelial cells in lesion formation. Am J Pathol (1995) 0.95
Hepatic expression of apolipoprotein E inhibits progression of atherosclerosis without reducing cholesterol levels in LDL receptor-deficient mice. Mol Ther (2000) 0.95
Nitric oxide activity in the atherosclerotic human coronary circulation. J Am Coll Cardiol (1997) 0.94
Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women. Circulation (1999) 0.94
Sudden death during empiric amiodarone therapy in symptomatic hypertrophic cardiomyopathy. Am J Cardiol (1991) 0.93
Regional extraction of circulating norepinephrine, DOPA, and dihydroxyphenylglycol in humans. J Auton Nerv Syst (1991) 0.93